RCS - Caldwell Partners - Caldwell Addition Dr. Christoph Themel as Partner

Caldwell Partners InternationalAnnouncement

03/02/2026 11:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260203:nRSC4160Ra&default-theme=true

RNS Number : 4160R  Caldwell Partners International  03 February 2026

Caldwell Strengthens Life Sciences and Healthcare Practice with Addition of
Dr. Christoph Themel as Partner

TORONTO, ON AND LONDON, UK / ACCESS Newswire (https://www.accessnewswire.com/)
/ February 3, 2026 / Retained executive search firm Caldwell
(TSX:CWL)(OTCQX:CWLPF) today announced the addition of Dr. Christoph Themel as
a Partner in the firm's Life Sciences and Healthcare Practice. Based in
London, Dr. Themel advises boards, investors, and senior leadership teams on
executive and non-executive appointments, leadership assessments, and
succession planning across the pharmaceutical, biotechnology, and animal
health sectors.

Dr. Christoph Themel joins Caldwell as partner in the firm's Life Sciences and
Healthcare Practice
(https://app.accessnewswire.com/imagelibrary/3dc03022-7a66-4be5-a373-f4973a369aad/1132337/christoph-themel.jpg)

With more than 20 years of experience in executive search and leadership
advisory, Dr. Themel is a trusted advisor to big and mid-sized pharmaceutical
companies, family-owned enterprises, private equity firms, and portfolio
company leadership teams across Europe, the United States, and Asia Pacific.
He is particularly known for his ability to partner closely with shareholders
and management teams on C-suite succession, senior-level development, and
organizational effectiveness initiatives.

"Christoph brings exceptional depth in life sciences and healthcare, combined
with a thoughtful, relationship-driven advisory style that resonates strongly
with boards and leadership teams," said John Blank, managing partner of
Caldwell's Life Sciences and Healthcare Practice. "He joins Caldwell at a
moment when leadership in this sector is becoming increasingly complex and
globally interconnected, so his ability to advise boards and investors on
succession, organizational design, and long-term leadership capability across
markets will be a significant asset to our clients and to the continued
evolution of our firm."

Dr. Themel has extensive experience delivering executive search, management
appraisal, and leadership development engagements in evolving and highly
regulated environments. His work is characterized by a strong focus on
aligning leadership capability with business strategy and culture, while
fostering environments of inclusion, innovation, and impact.

Prior to joining Caldwell, Dr. Themel was a Partner in the Healthcare and Life
Sciences Practice at a top-tier global executive search firm. Earlier in his
career, he was a partner at a boutique executive search firm specializing in
life sciences, with offices around the globe.

"Christoph's appointment reflects our continued investment in building a
strong, globally integrated Life Sciences and Healthcare practice," said Chris
Beck, chief executive officer. "His international experience and sector depth
expand our leadership advisory capabilities and strengthen the value we
deliver to clients as they navigate increasingly complex and consequential
talent decisions."

About Caldwell

Caldwell is a leading retained executive search firm connecting clients with
transformational talent. Together with IQTalent, we are a technology-powered
talent acquisition firm specializing in recruitment at all levels. Through the
two distinct brands - Caldwell and IQTalent- the firm leverages the latest
innovations in AI to offer an integrated spectrum of services delivered by
teams with deep knowledge in their respective areas. Services include
candidate research and sourcing through to full recruitment at the
professional, executive and board levels, as well as a suite of talent
strategy and assessment tools that can help clients hire the right people,
then manage and inspire them to achieve maximum business results.

Caldwell's common shares are listed on The Toronto Stock Exchange (TSX:CWL)
and trade on the OTCQX Market (OTCQX:CWLPF). Please visit our website at
www.caldwell.com for further information.

For further information, please contact:

Caroline Lomot

Vice President, Marketing & Communications

Caldwell

clomot@caldwell.com

+1 516 830 3535

SOURCE: Caldwell Partners International, Inc.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAGBGDDIBGDGLX



            Copyright 2019 Regulatory News Service, all rights reserved